Big Data in Oncodermatology: Cutaneous Immunotherapy Toxicities and Beyond

Yevgeniy Semenov, M.D., M.A.
Assistant Professor in Dermatology at Harvard Medical School

Dr. Semenov’s clinical expertise includes cutaneous oncology with a focus on melanoma and supportive oncodermatology. His research interests include epidemiology of melanoma and non-melanoma skin cancer with an emphasis on improving outcomes and treatment selection for patients with advanced disease. As part of this clinical and research focus, Dr. Semenov provides care to patients experiencing skin side effects from chemotherapy and immunotherapy used for the management of advanced cancers.

He has published more than 70 papers in leading dermatologic and oncologic publications, including the Journal of the American Academy of Dermatology, Journal of the American Medical Association Dermatology, Journal of Investigative Dermatology, British Journal of Dermatology, Journal for Immunotherapy of Cancer, and the Journal of the National Cancer Institute. His research has established robust multi-institutional and population-level evidence on the epidemiology, treatment options, and downstream outcomes for cutaneous immunotherapy toxicities.

Zoom Link: https://miami.zoom.us/j/94194819136